Work

A simulation study to provide guidance for individuals transitioning from emicizumab to valoctocogene roxaparvovec

Year: 2024

Type: conference-paper

Source: Hämostaseologie

DOI: 10.1055/s-0044-1779109

Authors: S. Agarwal, C. Hermans, W. Miesbach, S. Pipe, R. Sidonio, D. Osmond, V. Newman, J. Henshaw, F. Peyvandi

Institutions: BioMarin (United States), Cliniques Universitaires Saint-Luc, University Hospital Frankfurt, University of Michigan, Emory University, Children's Healthcare of Atlanta, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4392664760

FWCI:

Cites:

Cited by:

Related to: 10